SCHEMBL17170286

SCHEMBL17170286

c1ccc(-c2ccc(N(c3ccc(-c4ccccc4)cc3)c3ccc(-n4c5ccccc5c5cc6c(cc54)Oc4ccccc4O6)cc3)cc2)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ L3MBTL1 Q9Y468 2/20 0.41
▸ KDM4E B2RXH2 1/20 0.41
▸ ATM Q13315 1/20 0.41
▸ TSPO P30536 1/20 0.36
▸ HDAC4 P56524 1/20 0.36
▸ RAC2 P15153 1/20 0.35
▸ RAC3 P60763 1/20 0.35
▸ CDC42 P60953 1/20 0.35
▸ RAC1 P63000 1/20 0.35
▸ EDNRA P25101 2/20 0.34
▸ EDNRB P24530 1/20 0.34
▸ KMT2A Q03164 2/20 0.32
▸ MAPK8 P45983 1/20 0.32
▸ IL1R1 P14778 1/20 0.32
▸ MEN1 O00255 1/20 0.31
▸ ALDH1A1 P00352 1/20 0.31
▸ MAPT P10636 1/20 0.31
▸ HTT P42858 1/20 0.31
▸ PTGER4 P35408 1/20 0.31
▸ NPY5R Q15761 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17170374 1.00 L3MBTL1 (0.41) L3MBTL1KDM4EATMTSPOHDAC4
SCHEMBL17170756 1.00 L3MBTL1 (0.41) L3MBTL1KDM4EATMTSPOHDAC4
SCHEMBL17170290 1.00 L3MBTL1 (0.41) L3MBTL1KDM4EATMTSPOHDAC4
SCHEMBL17170291 0.99 L3MBTL1 (0.41) L3MBTL1KDM4EATMTSPOHDAC4
SCHEMBL17170768 0.99 L3MBTL1 (0.41) L3MBTL1KDM4EATMTSPOHDAC4
SCHEMBL17170758 0.99 L3MBTL1 (0.41) L3MBTL1KDM4EATMTSPOHDAC4
SCHEMBL17170711 0.94 TSPO (0.34) L3MBTL1KDM4EATMTSPOHDAC4
SCHEMBL17170341 0.94 TSPO (0.34) L3MBTL1KDM4EATMTSPOHDAC4
SCHEMBL17170765 0.93 KDM4E (0.36) L3MBTL1KDM4EATMTSPOHDAC4
SCHEMBL17170707 0.93 TSPO (0.34) L3MBTL1KDM4EATMTSPORAC2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10756277-B2 Organic compound and organic electroluminescent device comprising the same DOOSAN SOLUS CO., LTD. (KR) 2020-08-25 — — US disclosed
US-20170170406-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT ELEMENT COMPRISING SAME DOOSAN CORPORATION (KR) 2017-06-15 — — US disclosed
US-20170170406-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT ELEMENT COMPRISING SAME DOOSAN CORPORATION (KR) 2017-06-15 — — US disclosed
WO-2015156580-A2 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT ELEMENT COMPRISING SAME 주식회사 두산 2015-10-15 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170170406-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT ELEMENT COMPRISING SAME OR10J3, ORC3, L1CAM L3MBTL1 609/4885KDM4E 909/4885ATM 1000/4885
US-10756277-B2 Organic compound and organic electroluminescent device comprising the same OR10J3, L1CAM, ICOSLG L3MBTL1 314/4885KDM4E 953/4885ATM 1280/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback